Analysis of over 250 novel synthetic opioids and xylazine by LC–MS-MS in blood and urine
Journal of Analytical Toxicology · 28.03.2024 · 48 (3) · 150-164
DOI: 10.1093/jat/bkae009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Analytical Toxicology, online erschienen am 23.02.2024. Verfasst von Katie Diekhans und 3 weiteren Autor:innen. Beteiligte Einrichtung: Office of the Chief Medical Examiner, 1 Newhall Street, San Francisco, CA, United States. Hauptthemen laut MEDLINE: Analgesics, Opioid, Drug Overdose. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: California Department of Public Health.
Abstract (Originalsprache)
Novel Synthetic Opioids (NSO) are frequently found in postmortem (PM) and human performance (HP) forensic toxicology casework, resulting in impairment and fatal overdoses. Developing a broad NSO method benefits public health, as it can be used to identify trends in potent opioid use to develop risk management programs. This project aimed to design a comprehensive, rapid and routine method for the selective analysis of over 250 novel synthetic opioids in blood and urine. This method rapidly extracted 150 µL of blood or urine via protein precipitation followed by size-exclusion filtration, evaporation and reconstitution. Separation and data acquisition were achieved on a 12 min LC–MS-MS method using an F5 column. Data processing was expedited with a custom built-in query created in-house that automated processing and enhanced quality assurance. Validation according to ASB/ANSI Standard 036 was performed and applicability of the method was assessed using proficiency test and authentic casework samples. Assessed in blood and urine qualitatively were 261 unique analytes including fentanyl analogs (fentalogs), nitazenes and other miscellaneous synthetic opioids. As 59 isomeric target analytes were placed into groups due to co-elution, there were 202 distinct acquired targets or target - groups. To demonstrate applicability, 27 proficiency test blood samples received over an approximate 4-year period were analyzed with 126 expected results assessed comprising 25 unique target analytes. Additionally, 617 fatal accidental overdoses within San Francisco in 2022 were retroactively analyzed by this method with almost 10% of cases containing a new NSO substance(s). Such trends and NSO substances were previously unknown in this community.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Office of the Chief Medical Examiner, 1 Newhall Street, San Francisco, CA, United States.
- Laboratory Medicine, University of California, San Francisco, San Fransisco, CA, United States.
ORCID-Profile: Megan Farley, Luke N Rodda
Förderung
- California Department of Public Health
Zitieren
APA
Diekhans, K., Yu, J., Farley, M., & Rodda, L. N. (2024). Analysis of over 250 novel synthetic opioids and xylazine by LC–MS-MS in blood and urine. Journal of Analytical Toxicology, 48(3), 150-164. https://doi.org/10.1093/jat/bkae009
Vancouver
Diekhans K, Yu J, Farley M, Rodda LN. Analysis of over 250 novel synthetic opioids and xylazine by LC–MS-MS in blood and urine. Journal of Analytical Toxicology. 2024;48(3):150-164. doi:10.1093/jat/bkae009
BibTeX
@article{Diekhans2024,
author = {Diekhans, Katie and Yu, Jihau and Farley, Megan and Rodda, Luke N},
title = {Analysis of over 250 novel synthetic opioids and xylazine by LC–MS-MS in blood and urine},
journal = {Journal of Analytical Toxicology},
year = {2024},
volume = {48},
number = {3},
pages = {150--164},
doi = {10.1093/jat/bkae009}
}
EUVIMED